計算生物學市場規模、佔有率、成長分析、按應用、按最終用途、按服務、按地區 - 行業預測，2024-2031 年

2022年全球計算生物學市場規模估值為57億美元，從2023年的67.5億美元成長到2031年的262.6億美元，預計在預測期內（2024-2031年）將成長。 18.5%。

由於藥物發現研究和開發的增加、對預測模型的需求激增以及政府資助計劃，計算生物學市場正在經歷快速成長。這個跨學科領域利用理論概念和電腦模擬來詳細探索生物系統，包括基因組學和藥理學。值得注意的進步包括人類基因組計劃，它展示了電腦在基因圖譜方面的強大功能。百濟神州和 Ambrx 等合作正在透過整合擴展遺傳密碼等創新平台來加強藥物開發。為了因應臨床試驗中不斷上升的成本和失敗率，製藥公司正在轉向預測模型，市場預計將大幅擴張。公共和私營部門投資的增加繼續增強了這個充滿活力的部門。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 技術進步
• 監管環境

計算生物學市場規模：依服務和複合年成長率（2024-2031）

• 市場概況
• 資料庫
• 基礎設施和硬體
• 軟體平台

計算生物學市場規模：按應用和複合年成長率（2024-2031）

• 市場概況
• 藥物發現與疾病建模
  • 目標識別
  • 目標檢驗
  • 先導化合物發現
  • 先導藥物最適化
• 臨床前藥物開發
  • 藥物動力學
  • 動態
• 臨床試驗
  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段
• 計算基因組科學
• 計算蛋白質體學
• 其他

計算生物學市場規模：依最終用途和複合年成長率（2024-2031）

• 市場概況
• 學術研究
• 製藥業
• 產業

計算生物學市場規模與複合年成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• DNAnexus, Inc.
• Illumina, Inc.
• Thermo Fisher Scientific, Inc.
• Schrodinger, Inc.
• Compugen
• Aganitha AI Inc.
• Genedata AG
• QIAGEN
• Simulations Plus, Inc.
• Fios Genomics
• Certara
• Chemical Computing Group ULC
• Dassault Systemes
• Genedata AG
• Insilico Biotechnology AG

結論和建議

Global Computational Biology Market size was valued at USD 5.7 billion in 2022 and is poised to grow from USD 6.75 billion in 2023 to USD 26.26 billion by 2031, growing at a CAGR of 18.5% during the forecast period (2024-2031).

The computational biology market is experiencing rapid growth, driven by increasing drug discovery R&D, a surge in demand for predictive models, and government funding initiatives. Leveraging theoretical concepts and computer simulations, this multidisciplinary field enables detailed exploration of biological systems, including genomics and pharmacology. Notable advancements include the Human Genome Project, which showcased the power of computing in genetic mapping. Collaborations, such as that between BeiGene and Ambrx, are enhancing drug development by integrating innovative platforms like the Expanded Genetic Code. With pharmaceutical companies shifting towards predictive modeling in response to rising costs and failure rates in clinical trials, the market is poised for significant expansion. Increased investment from both public and private sectors continues to bolster this dynamic sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Computational Biology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Computational Biology Market Segmental Analysis

Global Computational Biology Market is segmented by service, application, end-use and region. Based on service, the market is segmented into databases, infrastructure & hardware and software platform. Based on application, the market is segmented into drug discovery & disease modelling, preclinical drug development, clinical trial, computational genomics, computational proteomics and others. Based on end-use, the market is segmented into academic & research, pharmaceutical industry and industrial. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Computational Biology Market

The global Computational Biology market is projected to witness significant growth driven by the increasing demand for advanced computational tools for genome sequencing. As more sophisticated software becomes accessible, scientists can efficiently conduct tasks such as creating PCR primers, identifying restriction enzyme cut sites, and converting DNA sequences into amino acids. The expanding databases and sequence analysis tools empower researchers to extract valuable insights regarding gene structures and functions, thereby enhancing the drug development process. By pinpointing functionally relevant protein sequences from extensive datasets, these computational approaches facilitate the discovery of new therapeutic targets and enable the engineering of synthetic DNA sequences, which further promotes innovation and commercialization in biotechnology. This rapid advancement in sequencing technology and analytical tools is expected to substantially boost market revenue in the coming years.

Restraints in the Global Computational Biology Market

The global computational biology market faces significant constraints primarily due to a scarcity of skilled professionals and a lack of standardized practices. Expertise in this field requires a strong foundation in programming, mathematics, and statistics, along with a comprehensive understanding of cloud computing and biological sciences. The interdisciplinary nature of computational biology often results in an absence of a cohesive curriculum, which may impede the ability of recent graduates to enhance their skill sets effectively. Furthermore, the field currently lacks established methods for addressing issues such as allergic reactions and post-surgical complications, potentially hindering market revenue growth in the future.

Market Trends of the Global Computational Biology Market

The global computational biology market is experiencing a robust upward trend, primarily fueled by the surge in clinical studies focused on pharmacogenomics, which enhances understanding of diverse patient populations' biological frameworks. This growing emphasis on personalized medicine, along with the need for rapid drug discovery and streamlined scientific research processes, is driving demand for computational biology solutions. Moreover, the increasing integration of computational tools across epigenomics, proteomics, and metagenomics sectors is pivotal in elucidating protein structures and interactions. Coupled with significant advancements in disease modeling and drug development, alongside heightened R&D investment from both private and public entities, the market is poised for sustained growth.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape

Global Computational Biology Market Size by Service & CAGR (2024-2031)

• Market Overview
• Databases
• Infrastructure & Hardware
• Software Platform

Global Computational Biology Market Size by Application & CAGR (2024-2031)

• Market Overview
• Drug Discovery & Disease Modelling
  • Target Identification
  • Target Validation
  • Lead Discovery
  • Lead Optimization
• Preclinical Drug Development
  • Pharmacokinetics
  • Pharmacodynamics
• Clinical Trial
  • Phase I
  • Phase Ii
  • Phase Iii
  • Phase Iv
• Computational Genomics
• Computational Proteomics
• Others

Global Computational Biology Market Size by End-Use & CAGR (2024-2031)

• Market Overview
• Academic & Research
• Pharmaceutical Industry
• Industrial

Global Computational Biology Market Size & CAGR (2024-2031)

• North America (Service, Application, End-Use)
  • USA
  • Canada
• Europe (Service, Application, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Service, Application, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Service, Application, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Service, Application, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• DNAnexus, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schrodinger, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Compugen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aganitha AI Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genedata AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Simulations Plus, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fios Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Certara
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chemical Computing Group ULC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dassault Systemes
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genedata AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insilico Biotechnology AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations